Product Images Levetiracetam

This appears to be a table or chart showing different percentages related to the use of a placebo and two different doses of Levetiracetam Tablet for a group of 85, 97, and 101 individuals. However, without additional context it is not clear what these percentages represent or how they relate to each other.*

This text appears to show percentages for two groups, with the first group representing 10.4% and the second group representing 39.4%. There are also two labels shown, "Placebo (N-104)" and "tam 3000 mg/day (N-150)" indicating the number of participants in each group. It is possible that this information is related to a medical or clinical trial, but without further context it is not possible to determine the specifics.*

This text seems to be a statistical analysis of different treatments with the drug Levetiracetam. It shows the percentage difference of effectiveness between the Placebo group (N=97) and the Levetiracetam Tablet group (N=101), with a 45% improvement in the latter. Additionally, there are other percentages provided, possibly for different dosages or durations of treatment. However, without additional context or labels, it's impossible to determine what the other percentages mean.*

This is a medication information sheet for Levetiracetam tablets. The package insert provides complete dosage recommendations and it is advised to store the medication at 25°C (77°F) with excursions permitted up to 30°C (86°F). The medication should be kept out of the reach of children and dispensed in a tightly sealed container with child-resistant closure. The tablets are manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY and come in a 30 tablet bottle prescribed by a physician.*

This is a medication label that provides instructions on the dosage, storage, and dispensing of Levetiracetam tablets, which are used for treating epilepsy. The recommended storage temperature is 25°C, and the medication should be stored in a light-resistant container with a child-resistant closure. Patients are advised to keep the medication out of reach of children, and pharmacists are instructed to dispense a medication guide to each patient. The label also indicates that the tablets are manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY.*

This is a medication called L-EVETIRACETAM with a recommended dosage specified in the package insert. The tablets come in 1000mg and should be dispensed by a pharmacist with a medication guide to patients. It should be kept in a tight and light-resistant closure at controlled room temperature and be kept out of reach from children. The medication is manufactured by Sciegen Pharmaceuticals in Hauppauge, NY.*

This is a medication label with information about usual dosage, storage, and manufacturer details for Levetiracetam tablets, USP. The label advises keeping the medication out of reach of children and includes a warning about temperature storage limits. The package includes 1,000 tablets, with each tablet containing 250mg of medication. The label includes an NDC number and the manufacturer's name and address. The pharmacist is advised to dispense a medication guide to each patient.*

This text provides dosage information for LEVETIFACETAM tablets, along with storage instructions and precautions for dispensing the medication to patients. The medication should be kept in a tightly sealed, light-resistant container with a child-resistant closure and should be kept out of reach of children. The manufacturer is identified as ScieGen Pharmaceuticals, located in Hauppauge, NY. Additional dosage information is available in the package insert.*

This is a medication used for treating seizures. The package insert should be consulted for complete dosage recommendations. It should be stored at a controlled room temperature and kept away from children. It is manufactured by ScieGen Pharmaceuticals in New York and comes in the form of 250mg tablets. Pharmacists should dispense an accompanying medication guide to each patient. The NDC number for this medication is 50228-470-30.*

This is a medication information for Sorag S 277 Levetiracetam tablets, USP. The usual dosage information is not available and it is recommended to refer to the package insert for complete dosages. The medication should be kept at a controlled room temperature and dispended in a tight and light-resistant container with a child-resistant closure. The medication guide should be given to each patient and must be kept out of the reach of children. The tablets are manufactured by ScieGen Pharmaceuticals, Inc. located in Hauppauge, NY.*

This is a medication package insert with dosage recommendations and storage instructions. Tablets need to be stored between 15 to 30°C in a tightly sealed, light-resistant container with a child-resistant closure. The medication guide should be dispensed to each patient by the pharmacist. The medication should be kept away from children. The manufacturer of the medication is ScieGen Pharmaceuticals, Inc., located in Hauppauge, NY.*

This is a medication label containing information about the dosage, storage, and manufacturer of a drug called "S0 B oa 5P Tablets, USP." The recommended storage temperature is 25°C, and the medication should be kept out of the reach of children. The label instructs pharmacists to dispense an accompanying medication guide to each patient. The manufacturer of the medication is Scieen Pharmaceuticals, Inc, located in Hauppauge, NY.*

This is a medication information sheet that provides storage and dosage recommendations for Levetiracetam tablets, USP manufactured by ScieGen Pharmaceuticals. The recommended storage temperature is between 59 to 86°F. It also includes instructions to dispense the accompanying medication guide to each patient.*

This text provides information on usual dosage, storage, and dispensing instructions for a medication called "Levetira cetam G o Tamorrel. Tablets, USP" with a strength of 500mg. It recommends storing the medication in a tight, light-resistant container with a child-resistant closure and dispensing an accompanying medication guide to each patient. The medication is manufactured by ScieGen Pharmaceuticals, Inc. in Hauppauge, NY.*

This is a medication called LEVEtiracetam. The package should be consulted for the usual dosage recommendations. The medication should be stored at a controlled room temperature and dispensed in a light-resistant container with a child-resistant closure. Dispensing should be done by a pharmacist with an accompanying medication guide to each patient. The manufacturer of the medication is ScieGen Pharmaceuticals, Inc, located in Hauppauge, New York.*

Levetiracetam Tablets, USP with a strength of 750 mg is a medication to be stored at 25°C (77°F). It is important to keep it out of reach of children. The recommended dosage is mentioned in the package insert. The tablets are resistant to both moisture and light. The accompanying medication guide must be dispensed to each patient. The manufacturer of this medicine is ScieGen Pharmaceuticals, Inc located in Hauppauge, NY. The product code for this medicine is NDC 50228-472-30.*

This is a set of instructions for the usage and storage of an unnamed medication. The dosage details are available in the package insert, and the recommended storage is between 15 and 30°C. The medication should be kept out of the reach of children, and a medication guide should be dispensed to each patient. The manufacturer is ScioGen Pharmaceuticals, Inc. The text includes an error ("Leveti raceta m") and an unexplained phrase ("NO VARNISH").*